About HEC
Based in New Zealand, working globally.
We're a fractional health economics team for medtech, healthtech, pharma, digital health, wearables, and health systems preparing to raise, submit, expand, or evaluate.
The firm.
HEC is a New Zealand-based health economics consultancy with a global client base. We work with medtech, healthtech, pharma, digital health, wearables, and health systems preparing for capital raises, HTA submissions, and multi-jurisdiction market expansion.
Our model is fractional by design. Rather than charging for a one-off deliverable, we embed with your company as a team function, giving you access to principal-level health economics expertise on an agreement, with the analytical depth of a dedicated department and none of the overhead of a full-time hire.
Engagements run on HEX Platform™, our proprietary health economics modelling environment. Every model is live, versioned, and collaborative. Your team is inside it throughout, not waiting for a file at the end.
3 to 9
months per engagement
Typical engagement length. From a focused Series A asset to a full HTA submission cycle.
12+
jurisdictions of experience
Australia, New Zealand, the United Kingdom, the United States, Germany, France, Sweden, Japan, Singapore, Canada, and more.
HEX
Every new engagement runs on HEX Platform
A live, versioned, client-accessible model, not a locked Excel or TreeAge file at handover.
Why we do this
Health systems run on choices made under scarcity. Health economics is how we make those choices defensible.
Every funding decision a payer makes is, in effect, a decision to not fund something else. Our job is to capture that trade-off honestly: translating clinical and operational evidence into an economic story that holds up under scrutiny, and that helps the people on the other side of the table allocate constrained resources with confidence.
The team
People.
Abbas Al-Murrani
Founder and Principal Health Economist
Abbas leads HEC engagements and is the principal health economist on every client account. With a background spanning health economics, HTA submission, and multi-jurisdiction market access, he has led economic evaluations across Pharmac, MSAC/PBAC, and NICE frameworks.
He holds a Master's in Economics and a Bachelor's in Health Sciences (Public Health) from the University of Auckland, and sits on the committee of the Aotearoa Health Economics Network, the national body for health economists in New Zealand. He has spoken at the Digital Health Festival (Melbourne, Australia) and other sector events.
Advisors & network
A bench, not a brand.
Beyond the principal, HEC engagements draw on an extended network of advisors and contractors, including clinical specialists, biostatisticians, real-world evidence analysts, and jurisdiction-specific submission veterans, assembled per engagement. We name the advisors on your team in writing as part of the engagement letter, so you always know exactly who is on the model.
Our approach
How we approach the work.
Methodological rigour.
Every model follows published HTA methodological guidelines for the relevant jurisdiction. We do not take shortcuts that would expose a submission to methodological challenge.
Transparency by default.
Nothing in our model is a black box. Every parameter has a source. Every assumption has a rationale. Your team can interrogate the model without us in the room.
Jurisdictional fluency.
We know what Pharmac expects that NICE does not. We know where G-BA diverges from HAS. Jurisdictional literacy is not a footnote. It shapes model structure from the outset.
Speed without sacrifice.
Investor timelines and submission deadlines are real constraints. HEX Platform is built for fast, rigorous modelling, without compromising the methodological integrity that makes the model defensible.
Contact
Get in touch.
Send a message
Use the contact form →Location
Auckland, New Zealand
Serving clients across Europe, the United States, Australia, Asia-Pacific, and New Zealand
Book a 30-minute strategy call.
A call costs nothing. We will ask the right questions and tell you honestly whether we can help.
Book a call